Mergers and Inquisitions

DECEMBER 4, 2024

This sector is the most different in terms of valuation and technical analysis because of nuances around licensing, player salaries, and different revenue streams. Be prepared to discuss a recent sports deal (ideally involving a team or league) and have a rough idea of the trends, drivers, and valuation differences (see below).

Investment Banking 105

Investment Banking Bank Banking Investment 105

Solganick & Co.

OCTOBER 6, 2023

Business Valuation: Understand and obtain a professional valuation or estimate to understand the worth of your technology business. Running a compresensive and targeted M&A auction process will help to maximize the outcome including receiving multiple offers and driving valuation higher. Solganick & Co.

Sale 52

Sale Business Valuation M&A 52

Software Equity Group

SEPTEMBER 24, 2024

Often similar to an indication of interest (IOI) or a letter of intent (LOI), a term sheet serves as a basis for initial negotiations on critical issues like the target company’s valuation and the structure of the prospective deal. If the document functions like an IOI, it may only provide a range of valuations.

Negotiation 52

Negotiation Business M&A Valuation 52

MergersCorp M&A International

JANUARY 25, 2024

TSI is anchored by Turn Capital, the single-family office of Singaporean entrepreneur Joseph Phua, who established himself within Asia’s technology media and entertainment arena through multiple successful acquisition and investment deals in the region.

Investment 52

Investment M&A Mergers and Acquisitions Capital 52

Software Equity Group

APRIL 4, 2023

Our customer marketing manager worked closely with Product, which owned our Customer Advisory Board (CAB). We also put on an annual customer appreciation event, with speakers, tech stations, and entertainment. I regularly share insights and trends aimed at boosting valuations and facilitating smoother exits.

Sale 52

Sale Book-building Business M&A 52

Cooley M&A

JANUARY 25, 2023

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. The need for big pharma to fill looming revenue gaps as medicines lose marketing exclusivity is balanced against increasing caution in boardrooms about making large, risky bets.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40